Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Hair follicle stem cells and mitochondria are key for hair growth, and targeting their activity could lead to new hair loss treatments.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

VEGFR-2 activation is likely involved in hair follicle growth, survival, and development.

Polarized light therapy helps hair regrowth in alopecia areata patients.

The Siah1 and Siah2 genes are active in mouse skin development and hair growth, especially right after birth.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

Researchers created human cells that can turn into sebocytes, which may help study and treat skin conditions like acne.

Skin stem cells are crucial for maintaining and repairing skin, with potential for treating skin disorders and improving wound healing.

Changing hair follicle identity could potentially reverse balding.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

The document concluded that stem cells are crucial for skin repair, regeneration, and may help in developing advanced skin substitutes.

The document suggests that activating autophagy might help with regeneration by removing old and damaged cells.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

Researchers found potential new targets for treating melanoma and nonmelanoma skin cancers, and identified a possible cause and treatment for male pattern baldness and eczema.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

Minoxidil and photobiomodulation together improve hair growth better than minoxidil alone.

Hair loss caused by genetics and hormones; more research needed for treatments.

Surgical therapies for vitiligo vary in effectiveness, with combination therapy and medical tattooing recommended for better results.

Stem cells preservation in AGA could be a potential therapy, but more cases needed.

Finasteride helps female-pattern hair loss.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Dandruff is linked to changes in the immune system of hair follicles and skin.

New treatments for hair loss could involve using stem cells and a process called the Wnt/beta-catenin pathway to stimulate hair growth.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Fibrosis in the bulge area of hair follicles can cause hair thinning in male pattern baldness, and drugs that inhibit fibrosis might help reverse this.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

iPSC-derived stem cells on a special membrane can help repair full-thickness skin defects.